Published online Sep 20, 2023. doi: 10.5662/wjm.v13.i4.248
Peer-review started: April 10, 2023
First decision: June 1, 2023
Revised: June 8, 2023
Accepted: July 25, 2023
Article in press: July 25, 2023
Published online: September 20, 2023
Processing time: 163 Days and 4.4 Hours
There is a need for new techniques to assess risk in patients with both coronavirus disease 2019 (COVID-19) and carbon monoxide (CO) poisoning, and techniques to aid rapid diagnosis.
The impact of emergency room patients with COVID-19 and CO poisoning on clinical status, morbidity and morbidity is worth investigating.
We aim to determine whether patients with COVID-19 and CO poisoning, as the primary outcome, are definite risk factors for short-term emergency hospitalization and whether there is long-term morbidity and mortality during hospitalization as a secondary outcome.
This single-center retrospective study was conducted between January 2018 and December 2021, and included 479 CO poisoning patients. The patients were divided according to the pandemic period and the pre-pandemic period. In addition, the pandemic period was classified according to the presence of COVID-19 and its clinical severity. Patients' demographic, clinical, arterial blood gas, COVID-19 polymerase chain reaction, and other laboratory data were extracted from the hospital information system.
The mean age of the 479 patients was 54.93 ± 11.51 years, and 187 (39%) were female. 226 (47%) patients were included in the pandemic group and 143 (30%) of them had a history of COVID-19. The mean potential of hydrogen (pH) in arterial blood gas of all patients was 7.28 ± 0.15, was 7.35 ± 0.10 in the pre-pandemic group, and was 7.05 ± 0.16 in the severe group during the pandemic period (P < 0.001). Carboxyhemoglobin (COHb) was 23.98% ± 4.19% in the outpatients and 45.26% ± 3.19% in the mortality group (P < 0.001). Partial arterial oxygen pressure (PaO2) was 89.63 ± 7.62 mmHg in the pre-pandemic group, and 79.50 ± 7.18 mmHg in the severe group during the pandemic (P < 0.001). While 35 (7%) of all cases died, 30 (85.7%) of those that died were in the pandemic group (P < 0.001). In the univariate linear analysis, the relationship between COHb, troponin, lactate, partial arterial pressure of carbon dioxide, bicarbonate, calcium, glucose, age, pH, PaO2, potassium, sodium, and base excess levels was statistically significant with the pre-pandemic and pandemic groups. In the receiver operating characteristic curve analysis, changes in COHb, lactate, and troponin due to CO poisoning were determined. Based on this analysis, the optimum cut-off values (sensitivity and specificity), the area under the curve, and the 95% confidence interval for COHb, lactate, and troponin were found to be above 45% in predicting the evolution of the pre-pandemic and pandemic groups (P < 0.001).
In cases with a history of COVID-19, CO poisoning was observed with more severe clinical and laboratory findings and more frequent mortality. We believe this will have critical implications for the diagnosis and treatment of COVID-19 in the future, as CO levels may be abnormal compared to healthy subjects and can be higher in mechanically ventilated patients.
CO poisoning in the pre-pandemic period appears to be milder than in the pandemic period. However, it was determined that mortality due to CO poisoning during the pandemic period was much higher in COVID-19 patients with a moderate and severe clinical course.